May 4, 2020 by Brian Orelli, PhDHere's Why Stemline Therapeutics Doubled OvernightThe ultimate binary event caused the biotech's shares to jump.
Apr 30, 2020 by Brian Orelli, PhDInovio Ramps Up Production of Its Coronavirus Vaccine CandidateThe biotech is moving quickly, but has a lot of potential competition.
Apr 29, 2020 by Brian Orelli, PhDPfizer and BioNTech Complete Dosing of First Group in Coronavirus Vaccine TrialThey're off to a fast start, but the companies still have a long ways to go.
Apr 24, 2020 by Brian Orelli, PhDAbbott's COVID-19 Test Is Fast, but Lab Personnel Are Worried About Their SafetyA report from Kaiser Health News highlights the issue.
Apr 23, 2020 by Brian Orelli, PhDJohnson & Johnson Taps Emergent BioSolutions to Help Manufacture Its COVID-19 VaccineThe contract is worth $135 million to Emergent BioSolutions.
Apr 22, 2020 by Brian Orelli, PhDRoche Increases Sales in the First Quarter: Benefits and Losses From the COVID-19 PandemicA new COVID-19 test can't overcome slow sales of Roche's drugs and diagnostics.
Apr 22, 2020 by Brian Orelli, PhDHere's Why Inovio Pharmaceuticals Jumped 18% TodayJim Cramer called out the vaccine maker.
Apr 20, 2020 by Brian Orelli, PhDBristol Myers Squibb's Cancer Drug Opdivo Successful in 2 Clinical TrialsIn combination with other drugs, Opdivo helped patients with kidney cancer and mesothelioma.
Apr 17, 2020 by Brian Orelli, PhDNew Swab for COVID-19 Test Doesn't Need to Be Shoved All the Way Up the NoseUsing the spun synthetic swab, people can collect their own test samples from the front of their nostrils.
Apr 16, 2020 by Brian Orelli, PhDGood News for COVID-19 Testing Companies: Medicare Nearly Doubles ReimbursementDiagnostic laboratories, rather than the test manufacturers, may be the biggest beneficiaries.
Apr 14, 2020 by Brian Orelli, PhDModerna Releases mRNA Vaccine Data, but Few Details About Its Coronavirus CandidateBased on the company's presentation, its underlying technology works. But questions remain regarding its hopeful SARS-CoV-2 vaccine.
Apr 10, 2020 by Brian Orelli, PhDBioCryst Is Testing Galidesivir for COVID-19The antiviral medication is in a phase 2 clinical trial in Brazil.
Apr 8, 2020 by Brian Orelli, PhDCSL Behring and Takeda Pharmaceutical Are Leading a Coalition to Develop a COVID-19 Hyperimmune TherapySix companies will work together to develop a plasma-derived antibody product to fight SARS-CoV-2.
Apr 6, 2020 by Brian Orelli, PhDGlaxoSmithKline and Vir Biotechnology Jump in Race to Treat and Prevent COVID-19The companies are taking multiple approaches to develop treatments and vaccines for the disease caused by the novel coronavirus.
Apr 5, 2020 by Brian Orelli, PhDGilead Has Treated More Than 1,700 COVID-19 Patients With RemdesivirThe biotech has manufactured enough doses to treat over 140,000 patients infected with the new coronavirus and is looking to further ramp up production.
Apr 3, 2020 by Brian Orelli, PhDFDA Urges COVID-19 Survivors to Donate Blood Plasma to Treat OthersThe plasma of people who have recovered from the novel coronavirus contains antibodies that could help current patients fight the infection.
Apr 3, 2020 by Brian Orelli, PhDFate Therapeutics Snags $3 Billion-Plus Deal With Johnson & JohnsonThe companies will be collaborating on immuno-oncology treatments.
Apr 2, 2020 by Brian Orelli, PhDIncyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19Both diseases involve an overactive immune system.
Apr 2, 2020 by Brian Orelli, PhDFDA: You Can Use Chloroquine to Treat COVID-19; EU Regulators: Not Just YetRegulators take different approaches to the unapproved medications.
Apr 2, 2020 by Brian Orelli, PhDPfizer, Merck, and Eli Lilly Will Pay Their Doctors to Get Back to Treating Patients During the COVID-19 PandemicThe pharma giants want to help any way they can, and that means letting their thousands of medical professionals go where they are most urgently needed.
![Abbott_Coronavirus_Test[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F568305%2Fabbott_coronavirus_test1.jpg&w=384&op=resize)
